Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury

Autor:	Teixiera, J., Atta, M.G., Noureddine, L., Nguyen, S., O’Rourke, B., Tilles, A., Bornschlegl, S., LaPointe, E., Dietz, A., Nissenson, A., Blair, A., Parekkadan, B., Barcia, R.
Zdroj:	In Cytotherapy May 2021 23(5) Supplement:S20-S21
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect